Cargando…
Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020
This cross-sectional study examines within-class changes in US wholesale drug prices for brand-name medications from 2015 to 2020.
Autores principales: | Liu, Patrick, Dhruva, Sanket S., Shah, Nilay D., Ross, Joseph S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823226/ https://www.ncbi.nlm.nih.gov/pubmed/33481031 http://dx.doi.org/10.1001/jamanetworkopen.2020.35064 |
Ejemplares similares
-
What Is the Price Benchmark to Replace Average Wholesale Price (AWP)?
por: Curtiss, Frederic R.
Publicado: (2010) -
Competition and price among brand-name drugs in the same class: A systematic review of the evidence
por: Sarpatwari, Ameet, et al.
Publicado: (2019) -
Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019
por: Clemans-Cope, Lisa, et al.
Publicado: (2023) -
Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
por: Aaron, Micah B., et al.
Publicado: (2021) -
Off-patent drugs at brand-name prices: a puzzle for policymakers
por: Tallapragada, Naren P.
Publicado: (2016)